Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements

Other literature type, Article English OPEN
Penugonda, Kavitha; Lindshield, Brian;
(2013)
  • Publisher: Multidisciplinary Digital Publishing Institute
  • Journal: Nutrients,volume 5,issue 9,pages3,617-3,633 (issn: 2072-6643, eissn: 2072-6643)
  • Related identifiers: doi: 10.3390/nu5093617, pmc: PMC3798925
  • Subject: Nutrition. Foods and food supply | supplements | saw palmetto | prostate cancer | TX341-641 | phytosterols | fatty acids | prostate | serenoa repens | benign prostatic hyperplasia | Article

Saw palmetto supplements are one of the most commonly consumed supplements by men with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found significant improvements in BPH and lower urinary tract symptoms (LUTS) with saw palmetto supplement... View more
  • References (50)
    50 references, page 1 of 5

    1. Barnes, P.M.; Bloom, B.; Nahin, R.L. Complementary and Alternative Medicine Use among Adults and Children: United States, 2007; CDC National Health Statistics Report: Hyattsville, MD, USA, December 2008; pp. 1-23.

    2. Blumenthal, M.; Lindstrom, A.; Ooyen, C.; Lynch, M.E. Herb supplement sales increase 4.5% in 2011, despite still-weak economy, herb sales continue multi-year growth. HerbalGram 2012, 95, 60-64.

    3. Bishop, F.L.; Rea, A.; Lewith, H.; Chan, Y.K.; Saville, J.; Prescott, P.; von Elm, E.; Lewith, G.T. Complementary medicine use by men with prostate cancer: A systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2011, 14, 1-13.

    4. Bauer, C.; Ishak, M.; Johnson, E.; Beebe Dimmer, J.; Cooney, K. Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. Integr. Cancer Ther. 2012, 11, 83-89.

    5. Iehlé, C.; Délos, S.; Guirou, O.; Tate, R.; Raynaud, J.P.; Martin, P.M. Human prostatic steroid 5α-reductase isoforms-A comparative study of selective inhibitors. J. Steroid Biochem. Mol. Biol. 1995, 54, 273-279.

    6. Bayne, C.W.; Donnelly, F.; Ross, M.; Habib, F.K. Serenoa repens (Permixon): A 5α-reductase types I and II inhibitor-New evidence in a coculture model of BPH. Prostate 1999, 40, 232-241.

    7. Bayne, C.W.; Ross, M.; Donnelly, F.; Habib, F.K. The selectivity and specificity of the actions of the lipido-sterolic extract of Serenoa repens (Permixon) on the prostate. J. Urol. 2000, 164, 876-881.

    8. Habib, F.K.; Ross, M.; Ho, C.K.H.; Lyons, V.; Chapman, K. Serenoa repens (permixon) inhibits the 5α-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int. J. Cancer 2005, 114, 190-194.

    9. Anderson, M.L. A preliminary investigation of the enzymatic inhibition of 5α-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro. J. Herbal Pharmacother. 2005, 5, 17-26.

    10. Pais, P. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II. Adv. Ther. 2010, 27, 555-563.

  • Metrics
    No metrics available
Share - Bookmark